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Abstract
Background. Rotational atherectomy (RA) used in elderly patients treated with percutaneous coronary 
interventions (PCI) could enable revascularization or the omission of cardiac surgery. Knowledge about factors 
affecting the prognosis may improve the results of treatment.
Objectives. We aimed to assess the relationship of gender and age with long-term clinical outcomes 
expressed as major adverse cardiac and cerebrovascular events (MACCEs).
Material and methods. The study included 97 consecutive patients treated with PCI and RA at the mean 
age of 71. The study group contained 73.2% men and 26.8% women, 36.1% of patients older than 75 and 
63.9% younger than 75. The mean time of follow-up was 695.3 ±560.9 days. The rate of MACCEs (deaths, 
myocardial infarctions (MIs), reinterventions, coronary artery by-pass surgeries, or cerebral strokes (CSs)/
transient ischemic attacks (TIAs)) in the overall group of patients was calculated at 33.7%.
Results. The comparison of Kaplan–Meier survival curves did not depict significant differences in the fre-
quency of MACCEs for age (p = 0.36) and gender (p = 0.07). We noticed that the death rate was higher 
in females than in males and in patients older than 75 compared to those younger, and was statistically 
significant for age (p = 0.04). The rate of periprocedural complications was significantly higher among women 
than among men (p = 0.005) and in patients older than 75 compared to the younger ones (p = 0.003).
Conclusions. Age and gender are not significantly associated with an increased rate of MACCEs during 
follow-up in elderly patients treated with PCI and RA.
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Introduction
In the era of population aging and the increase in the per-
centage of elderly patients, differences in the therapeutic 
approach among this group of patients are of special im-
portance. A number of published studies have shown that 
age is associated with increased mortality and worse prog-
nosis in the follow-up period among hospitalized patients.1 
Poorer prognosis in the elderly is associated with several 
factors reflecting the functional changes in their organ-
isms. Some researchers even attempted to identify the most 
important independent risk factors and created a prognos-
tic index for this group of patients to estimate the prob-
ability of mortality, and thus, the possibility of interfering 
with these factors to prolong life in this group of patients.2 
One of the independent risk factors of increased mortality 
in patients after hospitalization is ischemic heart disease. 
Previously published studies have shown differences in re-
sponse to the established treatment regimens in the el-
derly group of patients, and that appropriate modification 
of the diagnostic and therapeutic processes in this group 
of patients may contribute to a significant improvement 
in treatment outcomes compared to younger patients.3,4 In-
creased calcification in coronary arteries is associated with 
a higher risk of ischemic heart disease and cardiovascular 
events as well as mortality in elderly patients.4 Rotational 
atherectomy (RA) as a device to facilitate percutaneous 
coronary interventions (PCI) is dedicated to patients with 
heavy calcified stenoses in the coronary arteries.5 The RA 
is  applicable to  elderly patients, although the  number 
of publications comparing the results of its use depend-
ing on age is limited. Several studies have shown that age 
is an independent risk factor for major adverse coronary 
events in this group of patients.6 In comparative studies, 
the relationship of gender and long-term treatment results 
in the case of orbital atherectomy in the group of patients 
with heavy calcified lesions in coronary arteries has not 
been demonstrated, while the  number of  publications 
on RA is very limited.7
Therefore, in  the  current study, we  aimed to  assess 
the relationship of gender and age with long-term clinical 
outcomes in patients treated with PCI and RA expressed 
as  major adverse cardiac and cerebrovascular events 
(MACCE).
Material and methods
Our study was a retrospective and partially prospective 
registry of 97 consecutive patients undergoing PCI with RA 
from 2002 to 2017 in the primary reference center. The ma-
jority of patients were included during the last 10 years. 
All patients were screened for risk factors, concomitant 
diseases, past PCI history, and medications. Procedural 
details, and in-hospital and long-term complications were 
collected. The maximum follow-up period was 2,315 days 
and the study endpoints were the rates of MACCE defined 
as the following: death (overall mortality), the requirement 
of target lesion revascularization expressed as endovascular 
reintervention or coronary artery by-pass grafting (CABG) 
operation, myocardial infarction (MI), and cerebral stroke 
(CS)/transient ischemic attack (TIA). All patients gave 
informed consent for the procedure. The study was ap-
proved by the institutional ethical board and conformed 
to the ethical principles for medical research involving 
human subjects of the 1975 Declaration of Helsinki.
Procedure
Patients were qualified for the  procedure according 
to the current guidelines.5 A Rotablator (Boston Scientific, 
Marlborough, USA) was used to perform the procedure. 
We evaluated the preprocedural risk with Euroscore II and 
Syntax score online calculators (http://euroscore.org/calc.
html and http://www.syntaxscore.com/calculator/start.
htm respectively). The risk was defined as: low (≤2%), in-
termediate (3–5%) and high (≥5%) for the EUROSCORE 
II and low (0–22 points), intermediate (23–32 points) and 
high (≥33 points) for the SYNTAX score.
Procedure-related complications
The rate of procedure-related complications consisted 
of the intraprocedural complications and periprocedural 
hospitalization, which occurred after the procedure un-
til discharge from the hospital. The procedure-related 
MI was defined according to the 3rd universal definition 
of MI.8 Coronary artery perforation was defined accord-
ing to the most common and recognized definition pro-
posed by Ellis at al.9 The procedure-related hematoma 
was included in the analysis when it demanded surgical 
intervention or/and blood products transfusion. Cardio-
genic shock was defined according to the current European 
Society Guidelines.10 We included all the deaths that oc-
curred during the procedure or after the procedure un-
til discharge from the hospital into the current analysis 
as overall mortality. The allergic reaction was found to be 
significant when it demanded prolonged hospitalization 
and parenteral or oral therapy with antiallergic specifics. 
Contrast-induced nephropathy was recognized according 
to the definition published by Mehran et al.11 Coronary ar-
tery dissection was defined according to the most common 
classification.12 Other technical complications associated 
with the RA procedure itself were reported in accordance 
with current recommendations regarding the use of RA 
in Europe.13 For periprocedural arrhythmias, we included 
persistent ventricular and supraventricular tachyarrhyth-
mias, and atrioventricular conductive disorders requiring 
additional pharmacological or interventional treatment 
(pacing or cardioversion). Slow-flow or no-reflow was de-
fined as TIMI (thrombolysis in myocardial infarction) flow 
grade 0 or 1.14
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Statistical analysis
Normal distribution was assessed with the Shapiro–Wilk 
test. The χ2 test was used to compare the categorical vari-
ables. For comparisons of continuous data, the Mann–
Whitney U test or the Student’s t-test were performed 
where applicable. The  log-rank test was performed for 
comparisons of Kaplan–Meier survival curves in selected 
subgroups. Univariate analysis of selected potential pre-
dictors of clinical outcomes defined as MACEEs was also 
performed. A probability of p < 0.05 was considered statis-
tically significant. The statistical analyses were conducted 
with STATISTICA v. 10.0 software (StatSoft, Inc., Tulsa, 
USA) and SPSS Statistics v. 24 (IBM Corp., Armonk, USA).
Results
The  overall group of  patients included 97 subjects 
in which successful rotablation was performed. Among 
them, there were 71 males (73.2%) and 26 females (26.8%), 
62 individuals older than 75 (63.9%) and 35 patients young-
er than 75 (36.1%). The distribution of patients within 
particular age groups depending on gender is presented 
in Fig. 1.
General characteristics
The mean age of the males was 70.8 ±10 years and fe-
males 73.8 ±9.2 years. Males were significantly more often 
smokers (69.6% vs 10%, p = 0.03) and their mean ejection 
fraction of the left ventricle (LVEF) was smaller (43.9% 
vs 51.4%, p = 0.036), while the only 2 cases qualified for 
the RA in salvage mode were females (p = 0.01).
Patients older than 75 had significantly smaller mean 
body mass index (BMI) values (26.7 kg/m2 vs 29.2 kg/m2; 
p = 0.04), and presented at admission significantly more 
often with unstable angina (UA; 28.3% vs 53.1%, p = 0.019) 
or non-significantly less often with stable angina and non-
ST segment elevation MI (NSTEMI). They also were quali-
fied significantly more often for the procedure in emergency 
mode (26.5% vs 6.9%, p = 0.002) and non-significantly less 
often in elective and urgent mode. Moreover, the older 
group of patients characterized with greater mean serum 
creatinine level (p = 0.005) and smaller glomerular fil-
tration rate (GFR) level (p < 0.001). All clinical data are 
presented in Table 1.
The mean EUROSCORE II value was higher in females 
compared to males; however, it was without statistical sig-
nificance (3.3% ±3.3% vs 9.4% ±18.4%, p = 0.4). The higher 
mean EUROSCORE II value was attributed to the fact that 
among females there were 2 extremely high-risk patients 
treated in salvage mode, which increased the mean val-
ue. A similar relation was found when the overall group 
was divided according to age, where the 2 patients were 
placed in the group of patients older than 75. The differ-
ence in the mean EUROSCORE II value between patients 
younger and older than 75 was significant (9.2% ±15.2% vs 
2.3% ±2.8%, p < 0.001). In the case of gender division, males 
were more often at low risk (44.6%) compared to moderate 
(35.4%) and high-risk patients (0.2%), and in comparison 
to women, each risk group did not differ significantly. 
Among women, the distribution in the low (34.8%), mod-
erate (34.8%) and high-risk (30.4%) cases was more even.
In patients younger than 75, there were more patients 
in the low-risk group (58.2%) in comparison to moderate 
(50.9%) and high-risk (9.1%) groups. Not surprisingly, op-
posite distribution was shown in patients older than 75, 
among whom most patients were in the high-risk group 
(45.4%), while in the moderate (39.4%) and low-risk (15.1%) 
groups, their number was smaller. The difference between 
younger and older patients was significant for the low-risk 
group (p = 0.001) and high-risk group (p < 0.001).
Pharmacotherapy
There were no statistically significant differences 
in pharmacological treatment between males and females. 
Patients older than 75 were treated significantly more of-
ten with clopidogrel as a second antiplatelet drug (83% vs 
100%, p = 0.01). This was mainly due to more frequent use 
of ticagrelor (8.3% vs 0%, p = 0.08) and prasugrel (6.7% vs 
0%, p = 0.12) in younger patients. The frequency of other 
medications did not differ significantly between patients 
younger and older than 75. This is presented in Table 2.
Lesion characteristics  
and procedural indices
The mean SYNTAX Score I value did not differ sig-
nificantly between males and females, and was greater 
in females (24.1 ±13 points vs 26.3 ±13.0 points, p = 0.45). 
Patients older than 75 were presented with greater mean 
SYNTAX Score I value compared to younger patients; 
however, the difference did not reach statistical signifi-
cance (28.1 ±13.4 points vs 22.1 ±13 points, p = 0.06). 
When comparing SYNTAX Score I groups, there were 
Fig. 1. Patient distribution in selected age intervals according to gender
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Table 1. General characteristics
Variable
Gender
p-value
Age [years]
p-value
male female <75 ≥75
Age [years] 70.8 ±10.0 73.8 ±9.2 0.13 65.4 ±5.8 82.6 ±4.0 <0.000
BMI [kg/m2] 27.9 ±6.3 28.9 ±4.6 0.50 29.2 ±7.0 26.7 ±3.1 0.04
Gender (males) – – 49 (79) 22 (62.8) 0.08
Diabetes 34 (49.3) 15 (60) 0.36 34 (56.7) 15 (44.1) 0.31
Hypertension 66 (95.6) 25 (100) 0.29 57 (95) 34 (100) 0.68
Hyperlipidemia 65 (94.2) 25 (100) 0.22 57 (95) 33 (97.1) 0.86
Obesity 18 (27.3) 6 (26.1) 0.91 18 (32.1) 6 (18.2) 0.27
Prior PCI 47 (73.4) 13 (61.9) 0.31 41 (75.9) 19 (61.3) 0.26
Prior MI 46 (66.7) 15 (65.2) 0.92 32 (59.2) 25 (73.5) 0.28
Prior CABG 10 (14.7) 4 (16) 0.87 11 (18.6) 3 (8.8) 0.43
PAD 19 (27.9) 3 (12) 0.11 16 (27.1) 6 (17.6) 0.44
COPD 9 (13) 5 (20) 0.40 7 (16.7) 7 (20.6) 0.24
CS/TIA 10 (14.5) 4 (16) 0.85 5 (8.3) 9 (26.5) 0.14
Heart failure 23 (33.3) 8 (32) 0.90 19 (31.7) 12 (35.3) 0.72
Smoking 48 (69.6) 10 (40) 0.03 38 (63.3) 20 (58.8) 0.71
Kidney failure 13 (18.8) 5 (20) 0.93 8 (13.3) 10 (29.4) 0.06
Clinical picture
stable angina
UA
NSTEMI
STEMI
36 (54.5)
17 (25.7)
13 (19.7)
3 (4.5)
9 (36)
8 (32)
7 (28)
1 (4)
0.11
0.55
0.39
0.90
32 (53.3)
17 (28.3)
9 (15.0)
2 (1.7)
14 (43.7)
17 (53.1)
1 (3.1)
0 (0)
0.38
0.019
0.08
0.29
Mode
elective
urgent
emergency
salvage
39 (56.5)
21 (30.4)
9 (13)
0 (0)
10 (40)
9 (36)
4 (16)
2 (8)
0.15
0.60
0.71
0.01
35 (60.3)
21 (36.2)
4 (6.9)
0 (0)
14 (41.2)
9 (26.5)
9 (26.5)
2 (5.9)
0.10
0.39
0.002
0.06
LVEF [%] 43.9 ±12.7 51.4 ±10.8 0.036 47.8 ±11.5 42.3 ±13.9 0.13
GFR [mL/min] 80.0 ±33.2 64.2 ±29.4 0.08 92.4 ±28.4 48.9 ±17.6 <0.000
Creatinine [µmol/L] 92.5 ±33.3 85.6 ±25.7 0.21 83.6 ±20.5 103.2 ±42.0 0.005
BMI – body mass index; CABG – coronary artery by-pass grafting; COPD – chronic obstructive pulmonary disease; CS – cerebral stroke; GFR – glomerular 
filtration rate; LVEF – left ventricle ejection fraction; MI – myocardial infarction; NSTEMI – non ST-segment elevation MI; PAD – peripheral artery disease; 
PCI – percutaneous coronary intervention; STEMI – ST-segment elevation MI; TIA – transient ischemic attacks; UA – unstable angina.
Table 2. Pharmacotherapy at discharge
Variable
Gender
p-value
Age [years]
p-value
male female <75 ≥75
ASA 71 (100) 26 (100) – 62 (100) 35 (100) –
Antiplatelets
clopidogrel
ticagrelor
prasugrel
ticlopidine
59 (88)
4 (6)
4 (6)
1 (1.5)
25 (96.2)
1 (3.8)
0 (0)
0 (0)
0.18
0.69
0.20
0.53
50 (83)
5 (8.3)
4 (6.7)
1 (1.7)
34 (97.1)
0 (0)
0 (0)
0 (0)
0.01
0.08
0.12
0.44
Oral antidiabetic 18 (26.1) 6 (25) 0.93 21 (35) 3 (9.1) 0.03
Insulin therapy 18 (26.1) 8 (32) 0.66 18 (30) 8 (23.5) 0.60
ACEis/ARB 33 (47.8) 10 (41.7) 0.65 27 (45) 16 (48.5) 0.78
Diuretic 34 (55.7) 10 (50) 0.95 23 (45.1) 21 (70) 0.28
β-blocker 64 (92.7) 24 (100) 0.59 56 (93.3) 32 (97) 0.77
Statin/fibrate 68 (98.5) 23 (95.8) 0.91 57 (96.6) 34 (100) 0.89
Anticoagulant 14 (20.3) 6 (25) 0.72 8 (13.3) 12 (36.4) 0.06
Nitrate 4 (5.8) 2 (8.3) 0.85 2 (3.3) 4 (12.1) 0.48
Ca-blocker 20 (29) 9 (37.5) 0.35 19 (31.7) 10 (30.3) 0.91
ASA – acetyl-salicylic acid; ACEi – angiotensin-converting enzyme inhibitors; ARB – aldosterone receptor blockers.
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no significant differences between males and females 
in the low (45.6% vs 35.7%, p = 0.51), intermediate (28.2% 
vs 28.6%, p = 0.98) and advanced lesions (26.1% vs 35.7%, 
p = 0.48). While considering patients in terms of age, there 
were significantly more patients with less advanced athero-
sclerotic lesions in the coronary arteries among patients 
younger than 75 compared to older patients (54.3% vs 28%, 
p = 0.04), whereas there was not a significantly greater 
percentage of patients older than 75 in the intermediate 
(36% vs 22.8%, p = 0.26) and high (36% vs 22.8%, p = 0.26) 
SYNTAX Score I group compared to younger patients.
Both in the case of the division into women and men and 
into patients over and under the age of 75, atherosclerotic 
lesions in type C according to American Heart Associa-
tion (AHA) classification were more frequent in com-
parison to type 2B lesions. Type C lesions occurred not 
significantly more often in males than in females (78.7% 
vs 71.4%, p = 0.56), and in patients older than 75 (84% vs 
73.5%, p = 0.33), while type 2B lesions occurred more often 
in females (28.6% vs 21.3%, p = 0.56) and patients younger 
than 75 (26.5% vs 16%, p = 0.33).
Females were treated significantly more often from right 
radial access compared to males (50% vs 25.9%, p = 0.04), 
while patients older than 75 were treated significantly less 
often with single stent implantation compared to younger 
patients (80% vs 60%, p = 0.03), and insignificantly more 
often with 2 or 3 stents. Lesion characteristics and proce-
dural indices are presented in Table 3.
Significantly more procedure-related complications 
occurred in females compared to males (46.1% vs 18.3%, 
p = 0.005). Also, older patients (>75 years) demonstrated 
a significantly higher frequency of procedure-related com-
plications (42.8% vs 16.1%, p = 0.003). More detailed char-
acteristics are presented in Table 4.
Table 3. Lesion characteristics and procedural indices
Variable
Gender
p-value
Age [years]
p-value
male female <75 ≥75
Direct indication was inability to:
cross with b.c.
dilate with b.c.
stent delivery
27 (40.3)
39 (58.2)
1 (1.4)
8 (34.8)
12 (52.2)
3 (13)
0.63
0.61
0.02
21 (36.2)
34 (58.6)
3 (5.2)
14 (43.7)
17 (53.1)
1 (3.1)
0.48
0.61
0.65
Mean burr diameter [mm] 1.49 ±0.20 1.43 ±0.30 0.26 1.47 ±0.20 1.47 ±0.20 0.57
Maximum burr diameter [mm] 1.5 ±0.20 1.4 ±0.20 0.27 1.48 ±0.20 1.48 ±0.30 0.69
Arteries
1
2
3
56 (78.9)
12 (16.9)
3 (4.2)
16 (64)
7 (28)
2 (8)
0.13
0.23
0.46
49 (80.3)
10 (16.4)
2 (3.3)
23 (65.7)
9 (25.7)
3 (8.6)
0.11
0.26
0.46
Stents
1
2
3
4
36 (54.5)
21 (31.8)
8 (12.1)
1 (1.5)
15 (60)
7 (28)
2 (8)
1 (3.6)
0.63
0.72
0.57
0.48
49 (80)
10 (16.4)
2 (3.3)
0 (0)
21 (60)
10 (28.6)
4 (11.4)
0 (0)
0.03
0.15
0.11
–
Stent length [mm] 26.2 ±10.2 24.0 ±8.5 0.51 26.6 ±11.0 24.1 ±7.6 0.49
Stent diameter [mm] 3.04 ±0.70 3.06 ±0.80 0.90 3.05 ±0.70 3.0 ±0.70 0.62
Balloon diameter before PCI [mm] 2.9 ±0.5 2.6 ±0.6 0.06 2.9 ±0.6 2.7 ±0.5 0.27
Post-dilatation 58 (87.9) 19 (76) 0.38 51 (89.5) 26 (76.5) 0.30
Balloon diameter after PCI [mm] 3.6 ±0.7 3.7 ±1.0 0.93 3.6 ±0.7 3.6 ±0.9 0.50
IVUS after PCI 18 (25.3) 3 (11.5) 0.29 15 (24.2) 6 (17.1) 0.56
Radiation dose [Gy] 1.97 ±1.20 1.9 ±1.2 0.77 2.04 ±1.40 1.8 ±0.8 0.89
Contrast volume [mL] 271 ±106 303 ±140 0.53 285 ±140 272.0 ±69.6 0.69
Type of PCI
POBA/DEB
DES
BMS
3 (4.4)
64 (94.1)
1 (1.5)
0 (0)
24 (96)
1 (4)
0.28
0.72
0.45
3 (5.2)
55 (94)
0 (0)
0 (0)
33 (94.3)
2 (5.7)
0.17
0.91
0.06
Vascular access
RRA
LRA
RFA
LFA
15 (25.9)
2 (3.4)
36 (62.1)
5 (8.6)
10 (50)
0 (0)
9 (45)
1 (5)
0.04
0.40
0.18
0.60
16 (34.8)
1 (2.2)
24 (52.2)
5 (10.9)
9 (28.1)
1 (3.1)
21 (65.6)
1 (3.1)
0.53
0.79
0.23
0.20
b.c. – balloon catheter; BMS – bare-metal stent; Cx – circumflex branch; DEB – drug-eluting balloon; DES – drug-eluting stent; Dg – diagonal branch; 
IVUS – intravascular ultrasound; LAD – left anterior descending branch; LFA – left femoral artery; LMCA – left main coronary artery; LRA – left radial artery; 
Mg – marginal branch; PCI – percutaneous coronary intervention; POBA – plain-old balloon angioplasty; RCA – right coronary artery; RFA – right femoral 
artery; RRA – right radial artery.
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Clinical outcomes and follow-up
Follow-up was completed among the  overall study 
group in 78 (80.4%) patients included into the study. Dur-
ing the mean time to the MACCE or follow-up without 
MACCE (695 ±560 days), MACCEs occurred in 26 patients 
(33.7%). Among the MACCEs, there were 14 deaths (53.8%), 
4 reinterventions (15.4%), 5 MIs (19.2%), 2 CS/TIA cases 
(7.7%), and 1 coronary artery by-pass grafting (CABG) 
 operation (3.8%).
The frequency of MACCEs was greater among females 
compared to males, however, without statistical significance 
(45.4% vs 28.6%, p = 0.32). This was mainly due to greater 
rate of reinterventions (9.1% vs 3.6%, p = 0.7) and deaths 
(27.3% vs 14.3%, p = 0.37). Also, the MACCEs rate was great-
er in patients older than 75 compared to those younger than 
75 (42.8% vs 28.6%, p = 0.38), and this was mainly the conse-
quence of greater rate of deaths among older patients (35.7% 
vs 8%, p = 0.04). This is presented in Table 5.
The Kaplan–Meier survival curve comparison between 
males and females confirmed that, despite the fact that 
the frequency of MACCEs was higher in women, there was 
no significant difference between those 2 groups (p = 0.07). 
This is presented in Fig. 2.
Similarly, the greater rate of MACCEs in patients older 
than 75 compared to those younger did not meet statistical 
significance in comparison of the Kaplan–Meier survival 
curves (p = 0.36). This is presented in Fig. 3.
Predictors of clinical outcomes
Univariate analysis of several selected factors revealed 
that among them, statistically significant relationships 
with MACCEs were achieved for the maximal burr di-
ameter (p = 0.03), the occurrence of procedure-related 
complications (p  =  0.015), the  mean EUROSCORE  II 
value (p = 0.02), and borderline relationship with obesity 
(p = 0.052). Considering the fact that age and gender were 
Table 4. Procedure-related complications
Variable
Gender
p-value
Age [years]
p-value
male female <75 ≥75
Overall rate 13 (18.3) 12 (46.1) 0.005 10 (16.1) 15 (42.8) 0.003
AD 3 (4.2) 2 (7.7) 0.49 3 (4.8) 2 (5.7) 0.85
CS 1 (1.4) 3 (11.5) 0.02 2 (3.2) 2 (5.7) 0.55
MI 2 (2.8) 1 (3.8) 0.79 2 (3.2) 1 (2.8) 0.91
Death 0 (0) 1 (3.8) 0.09 0 (0) 1 (2.8) 0.18
Bleeding 1 (1.4) 2 (7.7) 0.11 1 (1.6) 2 (5.7) 0.27
Hematoma 1 (1.4) 2 (7.7) 0.11 0 (0) 3 (8.6) 0.02
Rotawire disruption 0 (0) 1 (3.8) 0.09 0 (0) 1 (2.8) 0.18
Arrhythmias 2 (2.8) 0 (0) 0.38 1 (1.6) 1 (2.8) 0.67
Allergic reaction 1 (1.4) 0 (0) 0.54 1 (1.6) 0 (0) 0.45
Slow flow 1 (1.4) 0 (0) 0.54 0 (0) 1 (2.8) 0.18
CIN 1 (1.4) 0 (0) 0.54 0 (0) 1 (2.8) 0.18
AD – arterial dissection; CIN – contrast-induced nephropathy; CS – cerebral stroke; MI – myocardial infarction.
Table 5. Study endpoints and duration of follow-up in selected groups of patients
Variable
Gender
p-value
Age [years]
p-value
male female <75 ≥75
Completed follow-up 56 (78.9) 22 (84.6) 0.90 50 (80.6) 28 (80) 0.88
Mean time of follow-up [days] 727 ±536 614 ±625 0.18 677 ±541 726 ±603 0.80
MACCE 16 (28.6) 10 (45.4) 0.32 14 (28.6) 12 (42.8) 0.38
Mean time to MACCE [days] 638 ±573 324 ±435 0.09 574 ±634 451 ±415 0.95
Re-PCI 2 (3.6) 2 (9.1) 0.70 4 (8) 0 (0) 0.55
Death 8 (14.3) 6 (27.3) 0.37 4 (8) 10 (35.7) 0.04
CS/TIA 1 (1.8) 1 (4.5) 0.85 1 (2) 1 (3.6) 0.90
MI 4 (7.1) 1 (4.5) 0.34 4 (8) 1 (3.6) 0.19
CABG 1 (1.8) 0 (0) 0.90 1 (2) 0 (0) 0.88
CABG – coronary artery by-pass grafting; CS – cerebral stroke; MACCE – major adverse cardiac and cerebrovascular events; MI – myocardial infarction; 
PCI – percutaneous coronary intervention; TIA – transient ischemic attack.
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not among the  factors associated with the occurrence 
of MACCE in the follow-up period, a multivariate analysis 
was not performed.
Discussion
The crucial finding of the presented analysis is  that 
gender and age greater than 75 were not found to be sig-
nificantly related to poorer clinical outcomes expressed 
as MACCE rate during the long-term follow-up period 
compared with survival curves. However, it  should 
be noted after the  analysis of  individual components 
of MACCEs, for both women and patients in  the  age 
group above 75, the incidence of deaths was higher, and 
in the case of age-related differences, mortality was statis-
tically significantly greater in the group of older patients. 
The univariate analysis did not confirm the relationship 
of age and gender with MACCEs during the follow-up 
period. Instead, it revealed that the maximal burr diam-
eter, EUROSCORE II value and the presence of proce-
dure-related complications are associated with long-term 
clinical outcomes after RA. The relationship between 
the  EUROSCORE II value and the length of the implanted 
stent was demonstrated in a previously published paper.15 
The level of perforations in the presented study was high-
er (3.1%) when compared to the published results based 
on large registries (0.3–1.1%).16,17 However, coronary per-
forations observed in our analysis were not complicated 
by serious and life-threatening incidents, including car-
diac tamponade and surgical treatment. They were treated 
successfully with an endovascular approach. Moreover, 
usually registries, including the Polish National Registry, 
underestimate the rate of procedure-related complica-
tions.18,19 The frequency of the overall procedure-related 
complication rates was significantly greater in females and 
in the group of patients older than 75. In the case of age, 
this was mainly due to the greater number of arterial dis-
sections, cardiogenic shocks and MIs, while in the case 
of  the  female gender, arterial dissections, cardiogenic 
shocks, arterial perforations, and hematomas demand-
ing blood transfusion or surgical treatment were more 
frequent.
Some published studies estimating the  relationship 
between age and long-term clinical outcomes in patients 
with heavy calcified coronary artery lesions demonstrated 
that age is an independent risk factor of poorer clinical 
outcomes expressed as MACCE.6 However, most of them 
did not confirm a significant relationship between age and 
long-term clinical outcomes, and among the factors that 
have independent influence on the prognosis, they con-
firmed LVEF, diabetes, cardiogenic shock, acute coronary 
syndrome, kidney failure, SYNTAX score, neutrophil/lym-
phocyte ratio, burr to artery ratio, or prior PCIs.20–23 Most 
of  these studies involved several hundreds of patients. 
Considering the various components of MACCE, Abdel-
Wahab et al. demonstrated that age was an independent 
predictor of target lesion revascularization.20 Our study 
included only about 100 participants, which makes it one 
of the smaller studies among those discussed. As a con-
sequence, the results are very susceptible to bias. One 
of the factors that certainly influenced the bias was the se-
vere state of some patients qualified for RA at a young age 
for the present cohort of patients, which were the causes 
of MACCE occurrence during the hospital stay or shortly 
after discharge. Operators are less likely to perform he-
roic rotablation treatments in older patients with multiple 
risk factors, which undoubtedly influenced the artificial 
masking of mortality in the early periprocedural stage 
in patients over 75.
Fig. 3. The comparison of Kaplan–Meier survival curves according 
to the age of 75
Fig. 2. The comparison of Kaplan–Meier survival curves according 
to gender
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Moreover, we did not break down MACCE into individual 
components in order to assess the impact of age and gender 
in survival curve analysis on long-term treatment results due 
to an insufficient number of endpoints in individual groups 
of patients and the resulting high probability of error and 
bias. However, we performed such a comparison of study 
endpoints for both groups and showed almost twice as high 
mortality in the follow-up period in women and patients 
over the age of 75, although this difference was statistically 
significant only for older patients. Nonetheless, in the case 
of women, this relationship can be explained by the higher 
mean value of the initial EUROSCORE II, which was mainly 
associated with a greater number of salvage mode proce-
dures, greater mean age and more procedure-related com-
plications. On the other hand, it should also be noted that 
women initially had a statistically significantly higher mean 
LVEF and they smoked cigarettes less frequently, which 
in some way influenced mortality balance and made it sta-
tistically non-significant. In the case of older age, the mor-
tality rate was statistically significantly higher in the group 
of patients older than 75, which was in line with other factors 
closely related to increased mortality as serum creatinine, 
GFR, mean SYNTAX score value, or mean EUROSCORE 
II value. In addition, the age of the patients and the aging 
of the body were also of great importance, as exemplified 
by the occurrence of deaths in patients above 90 years of age 
after a period of just over 200 days of the follow-up period. 
There are no publications attainable in the available litera-
ture that closely compare the long-term clinical outcomes 
of patients with severely calcified lesions of coronary arteries 
using RA. On the other hand, studies estimating the influ-
ence of individual factors on the results of treatment did 
not show that gender was related to treatment outcomes 
presented as MACCE prevalence. One of the few available 
studies on the treatment of similar coronary artery lesions, 
but undertaken with the use of another device, regards or-
bital atherectomy.7 This study was conducted on a relatively 
large group of patients including 458 participants. The in-
cidence of MACCE did not differ significantly between 
the 2 groups and was 0.7% and 2.7%, respectively, for women 
and men (p = 0.14). Admittedly, the incidence of MACCE 
in this study was higher in men than women. One of the fac-
tors that could have an impact on the incidence of MACCE 
in this study was higher mean length and diameter of stents 
in men compared to women, which was shown to be re-
lated to the incidence of MACCE in the follow-up period 
in other studies, including those published by our center.15 
On the other hand, in this study, the men were statistically 
significantly younger and less likely to have hypertension 
and hypercholesterolemia. Men were also insignificantly 
younger in our study, which certainly influenced the results.
Considering the  relationship of  procedure-related 
complications with gender and age, it  turned out that 
the incidence of complications in both women and older 
individuals is greater. Already in a previously published 
publication by our center, we demonstrated on a  large 
group of patients that the incidence of arterial perfora-
tions was related to age, and that age is an independent 
predictor of increased risk of their occurrence,18 which 
is in contrast, for example, to acute coronary syndromes 
that have not been shown to be significantly associated 
with the incidence of procedure-related complications.24 
The  increased rate of procedure-related complications 
is mainly caused by calcifications in the coronary arter-
ies, which predispose to typical complications of RA such 
as dissections or perforations.16,25 Previously published 
studies on the association of gender with periprocedural 
complications treated with PCI indicate a greater suscep-
tibility of women to procedure-related complications.26 
This trend also seems to be sustained for PCI with RA.
Conclusions
The negative relationship of age and gender with clini-
cal outcomes expressed as  increased rate of  MACCEs 
in elderly patients treated with PCI and RA does not have 
as much impact as  in the case of patients in other age 
groups, which should encourage operators to reduce their 
concerns in the treatment of patients over 75 years of age 
with rotablation.
Study limitations
The results of the presented work should be received with 
great caution, because the influence of age on poorer results 
in the follow-up period seems to be evident in all groups 
of patients treated with percutaneous coronary angioplasty, 
although the purpose of this article is to show that well-
prepared and stable patients among the elderly may achieve 
comparable benefits from the use of rotablation compared 
to younger patients. In the current work, apart from a very 
small group of patients as for this type of treatment and a rela-
tively large number of patients lost in the follow-up period, 
there are a number of factors that artificially mask the ac-
tual impact of age and sex on long-term treatment results. 
One of the main factors is undoubtedly the greater willing-
ness of the use of rotablation in the salvage mode, especially 
in younger and promising patients, compared to the older and 
less promising individuals burdened with many concomitant 
diseases, including cancer, heart failure and others, which 
artificially increased the number of deaths in the early peri-
procedural stage in patients under 75 years of age.
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